2389 (2389) Fair Value & Analysis
Healthcare · Market cap HK$460M
Fair value as of: Jul 2, 2026
From 3 valuation models · updated today
Share price +13.4% over the past month.
Price vs Fair Value (12 months)
12‑month range HK$0.0600 – HK$0.0950 · fair‑value band HK$0.0593 – HK$0.1199 · the HK$0.0760 price screens below the HK$0.0920 fair value. As of Jul 2, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
2389 (2389) currently trades at HK$0.0760, while our model-based Fair Value estimate is HK$0.0920 — implying the stock looks roughly 21.0% undervalued today. We read business quality at 50/100 (solid quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.
Over the trailing twelve months, 2389 generated revenue of HK$157M at a net margin of -64.2%. Revenue grew 5.2% year over year. It earns a return on equity of -5.8%. The balance sheet holds a net cash position of HK$26.4M. Fundamentals as of Jul 2, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
2389 reported revenue of HK$157M in FY2025 versus HK$204M in FY2021, a compound −6.3%/yr. Reported net income was −HK$101M in FY2025.
Is 2389 fairly valued? → Check now
Similar stocks
6 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc H1CA34 | R$95.75 | R$123.65 | +29% |
| Fresenius SE FSNUY | $11.47 | $8.55 | -25% |
| 5225 5225 | 8.71 MYR | 4.87 MYR | -44% |
| IHHHF IHHHF | $1.71 | $1.17 | -32% |
| Tenet Healthcare Corporation THC | $164.77 | $280.85 | +70% |
| Rede D'Or São Luiz S.A RDOR3 | R$32.50 | R$46.04 | +42% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is 2389 (2389) undervalued?
What is the fair value of 2389?
What is the quality score of 2389?
What is the revenue of 2389 (2389)?
What is the net profit margin of 2389?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.